Mail

UK markets closed

FTSE 100
8,285.71
+99.36(+1.21%)
FTSE 250
21,356.30
+471.95(+2.26%)
AIM
779.67
+6.64(+0.86%)
GBP/EUR
1.1844
-0.0006(-0.05%)
GBP/USD
1.2873
+0.0019(+0.14%)
Bitcoin GBP
53,418.51
+895.59(+1.71%)

8 champion homes in Olympic host cities

A selection of properties in former Games cities as Paris 2024 starts

Hikma Pharmaceuticals PLC (HIK.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)

Add to watchlist

1,896.00

+34.00

(+1.83%)

At close: 04:41PM BST

Currency in GBp

Valuation measures⁴

Market cap (intra-day)	4.21B
Enterprise value	4.96B
Trailing P/E	28.67
Forward P/E	12.20
PEG ratio (5-yr expected)	2.38
Price/sales (ttm)	1.89
Price/book (mrq)	2.46
Enterprise value/revenue	2.22
Enterprise value/EBITDA	11.54

Trading information

Stock price history

Beta (5Y monthly)	0.40
52-week change ³	-9.24%
S&P500 52-week change ³	18.96%
52-week high ³	2,222.00
52-week low ³	1,711.00
50-day moving average ³	1,910.12
200-day moving average ³	1,879.97

Share statistics

Avg vol (3-month) ³	315.66k
Avg vol (10-day) ³	242.54k
Shares outstanding ⁵	221.88M
Implied shares outstanding ⁶	221.89M
Float ⁸	154.7M
% held by insiders ¹	30.57%
% held by institutions ¹	38.19%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	0.57
Forward annual dividend yield ⁴	3.03%
Trailing annual dividend rate ³	0.72
Trailing annual dividend yield ³	0.04%
5-year average dividend yield ⁴	1.99
Payout ratio ⁴	72.75%
Dividend date ³	N/A
Ex-dividend date ⁴	21 Mar 2024
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	6.61%
Operating margin (ttm)	21.41%

Management effectiveness

Return on assets (ttm)	8.46%
Return on equity (ttm)	8.81%

Income statement

Revenue (ttm)	2.88B
Revenue per share (ttm)	13.02
Quarterly revenue growth (yoy)	11.00%
Gross profit (ttm)	N/A
EBITDA	791M
Net income avi to common (ttm)	190M
Diluted EPS (ttm)	0.66
Quarterly earnings growth (yoy)	293.30%

Balance sheet

Total cash (mrq)	229M
Total cash per share (mrq)	1.04
Total debt (mrq)	1.19B
Total debt/equity (mrq)	53.92%
Current ratio (mrq)	1.57
Book value per share (mrq)	9.94

Cash flow statement

Operating cash flow (ttm)	608M
Levered free cash flow (ttm)	445.25M